New MSF briefing paper outlines why deadly strains of DR-TB is one of the biggest global health threats we face today.

All you need to know about Tuberculosis, explained in six short web clips. Click here to watch the videos.

Activists demand rapid completion of intellectual property policy six years in the making; without internationally recognised public health safeguards policy will be health disaster.

Results also show viral suppression in one Malawian district twice as high as in the US

Yangon/New York, March 1, 2014 -- On February 27, Médecins Sans Frontières Holland (MSF) received a written order from the Union Government of Myanmar to cease all operations in the country, which led to a full closure of all MSF Holland clinics on February 28. This act left patients confused and desperately concerned across the whole country.

Tuberculosis patients are unable to receive their lifesaving medicine, including drug-resistant tuberculosis patients.

Despite minimal concessions, US demands remain extremely dangerous to all patients’ health across the Asia-Pacific region

Since June 2012, MSF has been treating prisoners and ex prisoners with drug-resistant tuberculosis (DR-TB) in the Donetsk region of Ukraine. Paola Mermati, MSF’s Field Coordinator in Donetsk, talks about the challenges of treating such patients successfully.  

New approaches to paediatric TB care should be integrated into every TB project and National TB programme.

Geneva/New York, 2 December 2013 - Ahead of the Global Fund replenishment conference in Washington, DC this week, international medical humanitarian organisation Médecins Sans Frontières (MSF) has warned the Global Fund to Fight AIDS, Tuberculosis and Malaria of the consequences of spearheading a new pricing initiative that could result in middle-income countries paying significantly higher prices for medicines to combat diseases, including HIV and tuberculosis.